Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4. This indicates a minor, internal update to the page version rather than a modification to its visible content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a newer page version. This appears to be a small maintenance update rather than a substantive change to study details.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2. This indicates a backend/template update, not new study data or visible content changes.SummaryDifference0.1%

- Check55 days agoChange DetectedRecruitment status is updated to indicate enrollment has ended. The page also shows a formatting change to the Intervention/Treatment label and adds a v3.6.0 revision note.SummaryDifference0.5%

- Check62 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new revision of the page. This update is a maintenance/version control change and does not alter the study details.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the page's revision history, indicating an update to the content. The previous Revision: v3.5.3 entry is superseded.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.